Ki67 of >=10% identifies an aggressive Group of PanNETs and lends support to emerging protocols in oncology literature utilizing this cut-off for closer follow-up and chemotherapy candidates

2024-11-0920220023-6837N/Ahttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174054/https://hdl.handle.net/20.500.14288/8812N/AMedicine, research and experimentalPathologyKi67 of >=10% identifies an aggressive Group of PanNETs and lends support to emerging protocols in oncology literature utilizing this cut-off for closer follow-up and chemotherapy candidatesMeeting Abstract1530-0307Q112309